Caricamento...
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib
BACKGROUND. Sunitinib is a standard treatment for metastatic clear cell renal cell carcinoma (mccRCC). Data on its activity in the rare variant of metastatic chromophobe renal cell carcinoma (mchRCC), are limited. We aimed to analyze the activity of sunitinib in a relatively large and homogenous int...
Salvato in:
Pubblicato in: | Oncologist |
---|---|
Autori principali: | , , , , , , , , , , , , , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
AlphaMed Press
2016
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061527/ https://ncbi.nlm.nih.gov/pubmed/27382030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0428 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|